By Bill Donahue Johnson & Johnson is facing a lawsuit that accuses the pharma giant of “rampant infringement” of copyrighted instrumental music in YouTube and Facebook videos. In a complaint ...
Johnson & Johnson is regaining momentum with ... I see a path to higher growth with less lawsuit risk, making the company a great pick in a market with an overall lofty valuation.